Obesity has been declared a disease by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a common ingredient in ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

The FDA approved Solensia ... included lethargy and extreme weight loss. “We suffer guilt, you know, because we made this ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

The company plans to expand Pemvidutide’s applications with a new IND for additional indications by year-end, enhancing its ...

New weight loss drug target reduces appetite and burns calories without sickness - The discovery could lead to a new ...